FreeMind

ABVC BioPharma Engages the FreeMind Group to Support Grant Funding

Retrieved on: 
Friday, May 13, 2022
NSF, Company, Stanford University, U.S. Securities and Exchange Commission, Patient, DOD, NASDAQ, Depression, NIH, San Francisco, FDA, FreeMind, CNS, University of California, San Francisco, Forward-looking statement, Cedars-Sinai Medical Center, University, Technology, Risk, Pancreatic cancer, Ophthalmology, PERT, SEC, Cancer, Security (finance), CA, BARDA, GLOBE, Pharmaceutical industry

FreeMind has a knowledgeable and experienced team of project managers with the ability to help ABVC identify the most suitable grant opportunities and assist in preparing and submitting the applications.

Key Points: 
  • FreeMind has a knowledgeable and experienced team of project managers with the ability to help ABVC identify the most suitable grant opportunities and assist in preparing and submitting the applications.
  • Over the last 10 years, their work has helped their clients to receive over $1.7 billion in non-dilutive funding.
  • We are hopeful that this collaboration will allow us to fund more of our promising clinical trials from non-dilutive capital sources, said Dr. Howard Doong, Chief Executive Officer of ABVC BioPharma.
  • ABVC BioPharma is a clinical-stage biopharmaceutical company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development.

Cannabis Products Up the 'Wow' Factor for the Holidays

Retrieved on: 
Friday, October 1, 2021
FreeMind, Forbes, Jacobs, Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., Smoke, Mg (magazine), New Year's Day, Holiday, Industry, Technology, Creativity, Gold, Borosilicate glass, Drug

With the holidays fast approaching, mg identified fall's hottest and most innovative cannabis products for every type of consumer.

Key Points: 
  • With the holidays fast approaching, mg identified fall's hottest and most innovative cannabis products for every type of consumer.
  • Luxury cannabis accessories brand Freeminded is trending for its $10,000 alligator-skin joint carrying case, a piece of exquisite craftsmanship for those interested in the ultra-pricey.
  • "Stocking a cannabis retail operation isn't easy," said Kathee Brewer, editorial director at Inc Media, mg Magazine's parent company.
  • The resulting list of thirty-four products provides some insight into what the future may hold for cannabis consumption across all categories, price points, and demographics.

Mydecine Innovations Group subsidiary NeuroPharm Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities

Retrieved on: 
Wednesday, October 14, 2020
Articles, Myco, Innovation, FreeMind, Application software

VANCOUVER, British Columbia, Oct. 14, 2020 (GLOBE NEWSWIRE) -- NeuroPharm, Inc. (NeuroPharm), a wholly-owned subsidiary of Mydecine Innovations Group, Inc., (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) announced today it has engaged FreeMind Group LLC to assist NeuroPharm in securing non-dilutive funding opportunities globally.

Key Points: 
  • VANCOUVER, British Columbia, Oct. 14, 2020 (GLOBE NEWSWIRE) -- NeuroPharm, Inc. (NeuroPharm), a wholly-owned subsidiary of Mydecine Innovations Group, Inc., (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) announced today it has engaged FreeMind Group LLC to assist NeuroPharm in securing non-dilutive funding opportunities globally.
  • FreeMind Group has the expertise to identify these funding sources and to assist NeuroPharm throughout the funding process, from the preparation and submission of funding applications to pre-award negotiations.
  • This should provide Mydecine Innovations Group with greater opportunities for success in the grant funding process.
  • About Mydecine Innovations Group Inc.
    Mydecine Innovations Group (CSE: MYCO) is a publicly traded life sciences syndicate, with offices in Denver, CO, USA and Vancouver, BC, Canada.

FreeMind Gives Free Access To All Premium Content To Alleviate Stress During COVID-19 Crisis

Retrieved on: 
Thursday, April 2, 2020
Operating systems, Computing, Smartphones, Computer architecture, IOS, Cloud clients, FreeMind, IPhone, Android, Smartphone, Meditations

FreeMind includes up to 14 forever-free meditations but is now giving full unrestricted access to all 280 meditations to help combat the spread of worldwide anxiety and stress brought on by the COVID-19 Coronavirus pandemic.

Key Points: 
  • FreeMind includes up to 14 forever-free meditations but is now giving full unrestricted access to all 280 meditations to help combat the spread of worldwide anxiety and stress brought on by the COVID-19 Coronavirus pandemic.
  • At the end of the free period, listeners can choose to maintain full access to FreeMind with a 50% monthly discount, or cancel the plan, which would still enable them to use the forever-free meditations.
  • To get the offer, FreeMind must be downloaded to an iPhone or Android smartphone and then follow the steps on the website .
  • A reminder will be sent for the opportunity to cancel before the free period ends on 1st October 2020.

FreeMind Gives Free Access To All Premium Content To Alleviate Stress During COVID-19 Crisis

Retrieved on: 
Thursday, April 2, 2020
Operating systems, Computing, Smartphones, Computer architecture, IOS, Cloud clients, FreeMind, IPhone, Android, Smartphone, Meditations

FreeMind includes up to 14 forever-free meditations but is now giving full unrestricted access to all 280 meditations to help combat the spread of worldwide anxiety and stress brought on by the COVID-19 Coronavirus pandemic.

Key Points: 
  • FreeMind includes up to 14 forever-free meditations but is now giving full unrestricted access to all 280 meditations to help combat the spread of worldwide anxiety and stress brought on by the COVID-19 Coronavirus pandemic.
  • At the end of the free period, listeners can choose to maintain full access to FreeMind with a 50% monthly discount, or cancel the plan, which would still enable them to use the forever-free meditations.
  • To get the offer, FreeMind must be downloaded to an iPhone or Android smartphone and then follow the steps on the website .
  • A reminder will be sent for the opportunity to cancel before the free period ends on 1st October 2020.